Status:
UNKNOWN
Evaluation of the Therapeutic Effect of Platelet Rich Plasma (PRP) in Periorbital Hyperpigmentation(POH)
Lead Sponsor:
Assiut University
Conditions:
Periorbital Hypermelanosis
Eligibility:
All Genders
20-50 years
Phase:
PHASE3
Brief Summary
To evaluate the saftey and efficicacy of autologous PRP in treatment of POH.
Detailed Description
Periorbital hyperpigmentation (POH) is a common dermatological condition, also known as periorbital melanosis, periocular hyperpigmentation dark circles under the eyes (DC), infraorbital discoloration...
Eligibility Criteria
Inclusion
- •Both sexes will be included.
- Age (20-50)
- Patient with Fitzpatrick skin types III-IV
Exclusion
- • Patients with known platelet dysfunction syndrome, critical thrombocytopenia (\<50,000/ul), any hemodynamic instability.
- Patients with chronic medical illness (e.g. diabetes, chronic infections, and blood dyscrasias).
- Patients with local inflammatory skin disorders or active herpes infection at the site of the procedure.
- Patients on consistent use of anti-coagulants or non-steroidal anti-inflammatory drugs (NSAID) within 48 hours of procedure.
- Haemoglobin level\< 10 g/dl were also excluded.
- Patients with cancer- especially hematopoietic or of bone.
- Pregnant females.
- Patients with corticosteroids injection at treatment site within 1 month or systemic use of corticosteroids within 2 weeks.
Key Trial Info
Start Date :
November 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03862118
Start Date
November 1 2019
End Date
December 1 2020
Last Update
March 6 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.